Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications

N Potere, MG Del Buono, R Caricchio, PC Cremer… - …, 2022 - thelancet.com
A hyperinflammatory response during severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection crucially worsens clinical evolution of coronavirus disease 2019 …

Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies

A Bonaventura, A Vecchié, TS Wang, E Lee… - Frontiers in …, 2020 - frontiersin.org
COVID-19 is a clinical syndrome ranging from mild symptoms to severe pneumonia that
often leads to respiratory failure, need for mechanical ventilation, and death. Most of the lung …

IL‐18 and infections: Is there a role for targeted therapies?

A Vecchie, A Bonaventura, S Toldo… - Journal of cellular …, 2021 - Wiley Online Library
Abstract Interleukin (IL)‐18 is a pro‐inflammatory cytokine belonging to the IL‐1 family, first
identified for its interferon‐γ‐inducing properties. IL‐18 regulates both T helper (Th) 1 and …

Left ventricular remodeling after myocardial infarction: from physiopathology to treatment

SA Leancă, D Crișu, AO Petriș, I Afrăsânie, A Genes… - Life, 2022 - mdpi.com
Myocardial infarction (MI) is the leading cause of death and morbidity worldwide, with an
incidence relatively high in developed countries and rapidly growing in developing …

Neutrophil extracellular traps and cardiovascular diseases: an update

A Bonaventura, A Vecchié, A Abbate, F Montecucco - Cells, 2020 - mdpi.com
Neutrophil extracellular traps (NETs) are formed by decondensed chromatin, histones, and
neutrophil granular proteins and have a role in entrapping microbial pathogens. NETs …

Damage-associated molecular patterns in myocardial infarction and heart transplantation: the road to translational success

MJM Silvis, SE Kaffka genaamd Dengler… - Frontiers in …, 2020 - frontiersin.org
In the setting of myocardial infarction (MI), ischemia reperfusion injury (IRI) occurs due to
occlusion (ischemia) and subsequent re-establishment of blood flow (reperfusion) of a …

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation

A Bonaventura, A Vecchié, L Dagna, F Tangianu… - Inflammation …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is capable of inducing the
activation of NACHT, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) …

Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in …

GF Wohlford, BW Van Tassell… - Journal of …, 2021 - journals.lww.com
The NLRP3 inflammasome has been implicated in the development and progression of
heart failure. The aim of this study was to determine the safety of an oral inhibitor of the …

Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health?

CJ McElwain, E Tuboly, FP McCarthy… - Frontiers in …, 2020 - frontiersin.org
Placental insufficiency and adipose tissue dysregulation are postulated to play key roles in
the pathophysiology of both pre-eclampsia (PE) and gestational diabetes mellitus (GDM). A …

Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction

MJM Silvis, EJ Demkes, ATL Fiolet, M Dekker… - Journal of …, 2021 - Springer
Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity
worldwide. Atherosclerosis is responsible for the majority of cardiovascular disorders with …